204 related articles for article (PubMed ID: 4301159)
1. [Animal experimental studies on various smallpox vaccines in a cowpox challenge experiment on white mice].
Herrlich A; Epp C; Mayr A
Z Immunitatsforsch Allerg Klin Immunol; 1968 May; 135(3):237-45. PubMed ID: 4301159
[No Abstract] [Full Text] [Related]
2. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
Coulibaly S; Brühl P; Mayrhofer J; Schmid K; Gerencer M; Falkner FG
Virology; 2005 Oct; 341(1):91-101. PubMed ID: 16061267
[TBL] [Abstract][Full Text] [Related]
3. [Experiments on the challenge of the antivaccinial transfer immunity of cell cultures by infection with variola virus. (Evaluation of the antivariola potency of smallpox vaccines)].
Stickl H
Zentralbl Bakteriol Orig; 1968; 208(4):473-85. PubMed ID: 4329545
[No Abstract] [Full Text] [Related]
4. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
[TBL] [Abstract][Full Text] [Related]
5. Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate.
Ferrier-Rembert A; Drillien R; Meignier B; Garin D; Crance JM
Vaccine; 2007 Nov; 25(49):8290-7. PubMed ID: 17964011
[TBL] [Abstract][Full Text] [Related]
6. Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.
Chen Z; Earl P; Americo J; Damon I; Smith SK; Zhou YH; Yu F; Sebrell A; Emerson S; Cohen G; Eisenberg RJ; Svitel J; Schuck P; Satterfield W; Moss B; Purcell R
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1882-7. PubMed ID: 16436502
[TBL] [Abstract][Full Text] [Related]
7. Bioterrorism. Smallpox vaccinations: how much protection remains?
Cohen J
Science; 2001 Nov; 294(5544):985. PubMed ID: 11691969
[No Abstract] [Full Text] [Related]
8. Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
Hughes CM; Newman FK; Davidson WB; Olson VA; Smith SK; Holman RC; Yan L; Frey SE; Belshe RB; Karem KL; Damon IK
Clin Vaccine Immunol; 2012 Jul; 19(7):1116-8. PubMed ID: 22593237
[TBL] [Abstract][Full Text] [Related]
9. Experimental infection of monkeys of the species Mac. rhesus with Pox-virus variolae and P. officinale after preimmunization with noninfectious antigen.
Danes L; Blazek K
J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):109-14. PubMed ID: 4288501
[No Abstract] [Full Text] [Related]
10. Response of camels to intradermal inoculation with smallpox and camelpox viruses.
Baxby D; Hessami M; Ghaboosi B; Ramyar H
Infect Immun; 1975 Apr; 11(4):617-21. PubMed ID: 164403
[TBL] [Abstract][Full Text] [Related]
11. [Pathological immune phenomena in virus diseases].
Lehmann-Grube F
Med Klin; 1970 Aug; 65(34):1472-6. PubMed ID: 4329530
[No Abstract] [Full Text] [Related]
12. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
13. Standardization of a neutralizing anti-vaccinia antibodies titration method: an essential step for titration of vaccinia immunoglobulins and smallpox vaccines evaluation.
Leparc-Goffart I; Poirier B; Garin D; Tissier MH; Fuchs F; Crance JM
J Clin Virol; 2005 Jan; 32(1):47-52. PubMed ID: 15572006
[TBL] [Abstract][Full Text] [Related]
14. Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.
Terajima M; Cruz J; Leporati AM; Demkowicz WE; Kennedy JS; Ennis FA
Hum Immunol; 2006 Jul; 67(7):512-20. PubMed ID: 16829305
[TBL] [Abstract][Full Text] [Related]
15. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
16. The viruses of variola, vaccina, cowpox and ectromelia. Neutralization tests on the chorio-allantois with unabsorbed and absorbed immune sera.
DOWNIE AW; McCARTHY K
Br J Exp Pathol; 1950 Dec; 31(6):789-96. PubMed ID: 14801363
[No Abstract] [Full Text] [Related]
17. Modified vaccinia Ankara: potential as an alternative smallpox vaccine.
McCurdy LH; Larkin BD; Martin JE; Graham BS
Clin Infect Dis; 2004 Jun; 38(12):1749-53. PubMed ID: 15227622
[TBL] [Abstract][Full Text] [Related]
18. [On persistence of vaccinia virus after smallpox vaccination. With a contribution to the problem of vaccinal immunity].
EHRENGUT W
Z Hyg Infektionskr; 1962; 148():230-40. PubMed ID: 13889504
[No Abstract] [Full Text] [Related]
19. Detection by radioimmunoassay of antibodies in human smallpox patients and vaccinees.
Ziegler DW; Hutchinson HD; Koplan JP; Nakano JH
J Clin Microbiol; 1975 Mar; 1(3):311-7. PubMed ID: 170309
[TBL] [Abstract][Full Text] [Related]
20. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
